1-3 of 3
Ilaria Libani
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Potential Use of Jak2 Inhibitors to Limit Ineffective Erythropoiesis and Reverse Splenomegaly in β-Thalassemia.

Luca Melchiori, Ella Guy, Ilaria Libani, Ph.D, Raffaella Schirò, MD, Ph.D, Pedro Ramos, Laura Breda, Ph.D, Amy Chadburn, MD, Yi-Fang Liu, Maria De Sousa, MD, Eliezer Rachmilewitz, M.D, Patricia J Giardina, MD, Robert W Grady, Ph.D, Stefano Rivella, Ph.D
Journal: Blood
Blood (2008) 112 (11): 1877.
https://doi.org/10.1182/blood.V112.11.1877.1877
Published: 2008
Journal Articles

Accelerated Proliferation and Limited Differentiation, Mediated through Jak2, Exacerbate Ineffective Erythropoiesis in β-Thalassemia.

Ella Guy, Ilaria Libani, PhD, Luca Melchiori, Thomas Scholzen, PhD, Raffaella Schiro, MD, Pedro Ramos, Margrit Kernbach, Bettina Baron-Luehr, Laura Breda, PhD, Matteo Porotto, PhD, Maria de Sousa, MD, Maria Domenica Cappellini, MD, Patricia J. Giardina, MD, Robert W. Grady, PhD, Johannes Gerdes, PhD, Stefano Rivella, PhD
Journal: Blood
Blood (2007) 110 (11): 275.
https://doi.org/10.1182/blood.V110.11.275.275
Published: 2007
Journal Articles

Ineffective Erythropoiesis in β-Thalassemia Is Characterized by Enhanced Survival Mechanisms That Reduce P21-Mediated Cell Death.

Ilaria Libani, Raffaella Schiro, Thomas Scholzen, Pedro Ramos, Ella Guy, Margrit Kernbach, Bettina Baron-Luehr, Laura Breda, Matteo Porotto, Maria Domenica Cappellini, Patricia Giardina, Johannes Gerdes, Stefano Rivella
Journal: Blood
Blood (2006) 108 (11): 649.
https://doi.org/10.1182/blood.V108.11.649.649
Published: 2006